Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Ankylosing spondylitis and bowel disease.

Dominique Baeten¹, Filip De Keyser, Herman Mielants

¹Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.

Best Practice & Research. Clinical Rheumatology

|October 31, 2002

Summary

Bowel inflammation is closely linked to ankylosing spondylitis and Crohn's disease. Therapies targeting Crohn's disease may treat both gut and joint inflammation in spondyloarthropathies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Targeting fibroblast-like synoviocytes with CDK4/6 inhibitors as a novel, non-immunosuppressive treatment strategy for rheumatoid arthritis.

Clinical and experimental rheumatology·2025

Same author

Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exploratory study with PET-CT imaging.

Therapeutic advances in musculoskeletal disease·2024

Same author

Real-world effectiveness of golimumab in the treatment of patients with active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who failed initial TNF-α inhibitor therapy: a pooled analysis of European prospective observational studies (the GO-BEYOND program)

Clinical and experimental rheumatology·2023

Same author

Differential regulation of IL-17A and IL-17F via STAT5 contributes to psoriatic disease.

The Journal of allergy and clinical immunology·2023

Same author

Prevalence and management of drug interactions between nonsteroidal anti-inflammatory drugs and antithrombotics in ambulatory care.

British journal of clinical pharmacology·2022

Same author

Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial.

JAMA dermatology·2021

Area of Science:

Rheumatology
Gastroenterology
Immunology

Background:

Bowel inflammation plays a significant role in ankylosing spondylitis and related spondyloarthropathies.
Gut inflammation in spondyloarthropathies shares clinical and histological similarities with Crohn's disease.
Subclinical immune alterations suggest spondyloarthropathy models early Crohn's disease.

Purpose of the Study:

To explore the relationship between bowel inflammation and spondyloarthropathies.
To investigate the link between gut and peripheral joint inflammation.
To identify potential therapeutic targets for spondyloarthropathies.

Main Methods:

Clinical and histological analysis of bowel and joint inflammation.
Evaluation of subclinical immune alterations.

Related Experiment Videos

Review of therapeutic interventions, including TNF-alpha blockade.

Main Results:

A strong clinical and histological link exists between gut inflammation in spondyloarthropathies and Crohn's disease.
Bowel and peripheral joint inflammation are interconnected clinically, histologically, and pathogenetically.
TNF-alpha blockade shows efficacy in treating both intestinal and extra-intestinal manifestations.

Conclusions:

Targeted therapies for Crohn's disease may benefit patients with spondyloarthropathies.
Understanding the gut-synovium axis can reveal new therapeutic strategies.
Assessing subclinical gut inflammation aids in patient stratification for personalized treatment.